Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.
Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.
复制标题
DOI:
10.1371/journal.pone.0244285
复制
发表时间:
2021
期刊:
影响因子:
3.7
通讯作者:
Bishehsari F
中科院分区:
文献类型:
--
作者:
Barlass U;Deshmukh A;Beck T;Bishehsari F
Pancreatic cancer (PC) rate is increasing in the U.S. The use of prescription and illicit opioids has continued to rise nationally in recent years as well. Opioids have been shown to have a deleterious effect on multiple types of cancer with recent data suggesting opium use as a risk factor for PC. Using national databases, we tested whether opioid usage pattern over time could explain the state and national-based variations in PC rates in the U.S. Opioid death rate (as a surrogate for prescription and illicit opioid use) was extracted from the CDCs Wonder online data through the Vital Statistics Cooperative Program. Incidence of pancreatic cancer was retrieved from the online CDCs data base gathered from the U.S. Cancer Statistics Working Group. Prevalence of obesity, tobacco and alcohol use was collected from Behavioral risk factor surveillance system. Mixed-effects regression models were used to test the association between levels of PC rate and opioid death/use rates during the years 1999–2016. A rise in PC was seen over time at the national and state levels. Similarly, the opioid death rates increased over time. Among other potential PC risk factors, only obesity prevalence showed an increase during the study period. A state’s opioid death rate at 4 years prior significantly predicted initial incidence of PC (β = 0.1848, p<0.0001) and had a significant effect on the estimated annual change in the rate of PC (β = -.0193,p<0.0001). Opioid use may be an un-identified risk factor contributing to the increasing incidence of PC in the U.S. These novel findings need to be verified by population-based studies.
登录
查看更多内容
影响因子:
1.6
作者:
Shakeri, Ramin;Kamangar, Farin;Pourshams, Akram
通讯作者:
Pourshams, Akram
影响因子:
13.8
作者:
Wu, Bechien U.;Butler, Rebecca K.;Chen, Wansu
通讯作者:
Chen, Wansu
DOI:
10.1016/j.bpg.2017.09.001
发表时间:
2017-10
期刊:
Best practice & research. Clinical gastroenterology
影响因子:
--
作者:
Korc M;Jeon CY;Edderkaoui M;Pandol SJ;Petrov MS;Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
通讯作者:
Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)
影响因子:
2.9
作者:
Chari ST;Kelly K;Hollingsworth MA;Thayer SP;Ahlquist DA;Andersen DK;Batra SK;Brentnall TA;Canto M;Cleeter DF;Firpo MA;Gambhir SS;Go VL;Hines OJ;Kenner BJ;Klimstra DS;Lerch MM;Levy MJ;Maitra A;Mulvihill SJ;Petersen GM;Rhim AD;Simeone DM;Srivastava S;Tanaka M;Vinik AI;Wong D
通讯作者:
Wong D
影响因子:
1.9
作者:
LAIRD, NM;WARE, JH
通讯作者:
WARE, JH